4.6 Review

Hypomagnesemia as a Risk Factor and Accelerator for Vascular Aging in Diabetes Mellitus and Chronic Kidney Disease

Journal

METABOLITES
Volume 13, Issue 2, Pages -

Publisher

MDPI
DOI: 10.3390/metabo13020306

Keywords

bone-mineral disorders; cardiovascular mortality; magnesium; nutrition supplement; prevention; vascular aging; vascular calcification; vascular smooth muscle cells

Ask authors/readers for more resources

The ongoing critical re-examination of modifiable risk factors in chronic kidney diseases shows that attempts to modulate vascular risk with cholesterol-lowering agents have failed. Pathological biochemical processes and decreased serum magnesium levels contribute to vascular calcification in chronic kidney damage, leading to cardiovascular complications. Simple oral magnesium supplementation may reduce cardiovascular mortality in severely affected patients, and the concept of 'normal' vs. 'ideal' serum magnesium levels needs to be re-evaluated.
The age-old axiom that one is as old as his or her vessels are, calls for ongoing critical re-examination of modifiable risk factors of accelerated vascular ageing in chronic kidney diseases. Attempts to modulate vascular risk with cholesterol-lowering agents have largely failed in advanced chronic kidney disease (CKD). In addition to nitrogen waste products, many pathological biochemical processes also play a role in vascular calcification in chronic kidney damage. Magnesium, a cation vital for the body, may substantially reduce cardiovascular diseases' risk and progression. This narrative review aimed to address the relationship between hypomagnesemia and vascular calcification, which promotes further cardiovascular complications in diabetes, aging, and CKD. Articles with predefined keywords were searched for in the PubMed and Google Scholar databases with specific inclusion and exclusion criteria. We hypothesized that a decrease in serum magnesium levels contributes to increased vascular calcification and thereby increases cardiovascular mortality. In summary, based on existing evidence in the literature, it appears that simple and inexpensive oral magnesium supplementation may reduce the cardiovascular mortality of patients who are already severely affected by such diseases; in this context, the concept of 'normal' vs. 'ideal' serum magnesium levels should be carefully re-examined.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available